US FDA Regulation of Human Cell and Tissue Products

Determining how medical products made from human cells or tissues are regulated by the government can often be daunting and difficult. This free white paper covers which regulations impact these products, classification rules, and some potential issues you can avoid.

Questions? Request more information from our specialists


Does your medical device contain animal or donated human cells or tissues? If so, you must meet complex regulations before you can market your device in the United States.

US Food and Drug Administration regulations for such devices, commonly referred to as HCT/Ps (Human Cells, Tissues, and cellular and tissue-based Products), are daunting and any misstep in the regulatory process can be costly and delay the clearance of your device. In this whitepaper, we'll answer your biggest questions regulatory issues specific to HCT/Ps, including:

  • What is a HCT/P?
  • How does the US FDA regulate HCT/Ps?
  • How are HCT/Ps classified by the FDA?
  • What is Tissue Bank Establishment registration?

Learn all this and more in this 6-page white paper.

About the Author
Audrey Swearingen is Director of Regulatory Affairs at Emergo's Austin, Texas headquarters. With over 20 years of experience in regulatory affairs, Audrey’s areas of expertise include US FDA medical device registration as well as European and Canadian device registration.